Founders, Fellows, & Advisors
Constellation’s founders and scientific advisors are pioneers, authorities and thought leaders within the fields of epigenetics, drug discovery, and clinical medicine. They have made innumerable contributions to our understanding of epigenetic biology and to the development of novel therapeutics.
Founders
Danny Reinberg, Ph.D.
Professor of Biochemistry, New York University School of Medicine
Howard Hughes Medical Institute Investigator
David Allis, Ph.D.
Professor and Head of the Laboratory of Chromatin Biology, Rockefeller University
Member of the National Academy of Sciences
Yang Shi, Ph.D
Professor of Cell Biology, HMS and Merton Bernfield Professor of Neonatology at Chilren's Hospital
Constellation Research Fellow
Edward Harlow, Ph.D.
National Cancer Institute – Special Assistant to the Director
Member of the National Academy of Sciences
Scientific Advisory Board
Stephen Baylin, M.D.
Deputy Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Arul Chinnaiyan, M.D., Ph.D.
Professor of Pathology and Urology, University of Michigan
Howard Hughes Medical Institute
Steven Gamblin, Ph.D.
Professor, National Institute for Medical Research at the Medical Research Council, UK
Thomas Jenuwein, Ph.D.
Director, Max Planck Institute
Rick Klausner, M.D.
Managing Partner, The Column Group
Former Director of the National Cancer Institute
Arnold Levine, Ph.D.
Professor, Institute for Advanced Studies
David Livingston, M.D.
Deputy Director, Dana Farber Harvard Cancer Center
Professor of Medicine and Genetics, Harvard Medical School
Scott Lowe, Ph.D.
Professor, Cold Spring Harbor Laboratory
Howard Hughes Medical Institute